We showed that this CR-1 interference treatment significantly reduced the proliferation, S-phase fraction (SPF), and migratory ability of ESCC cells, while significantly increasing their apoptotic activity. This evidence concerns the gene CR1 and esophageal squamous cell carcinoma.